Related Experiment Video
Updated: May 5, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Risk Factors, Indications, and Effectiveness of Cerebrospinal Fluid Diversion in Patients With High-Grade
Jovanna A Tracz1,2, Max A Saint-Germain1, Cathleen C Kuo3
1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore , Maryland , USA.
Insights
Cerebrospinal fluid (CSF) diversion significantly improves symptoms and functional status in patients with high-grade glioma (HGG)-associated hydrocephalus. This procedure may be recommended when patient functionality and symptom relief are priorities.
Area of Science:
- Neurosurgery
- Oncology
- Neurology
Background:
- High-grade glioma (HGG) can lead to hydrocephalus, a condition requiring cerebrospinal fluid (CSF) diversion.
- The role and effectiveness of CSF diversion in HGG patients with hydrocephalus remain debated.
- This study systematically reviews evidence on CSF diversion for HGG-associated hydrocephalus.
Purpose of the Study:
- To evaluate the effectiveness of CSF diversion in adult patients with HGG-associated hydrocephalus.
- To assess improvements in patient survival, functional status (Karnofsky Performance Status - KPS), and symptoms.
- To identify risk factors, indications, and complications associated with CSF diversion in this population.
Main Methods:
- Systematic review and meta-analysis of studies identified through PubMed, SCOPUS, CINAHL, Cochrane, and Embase.
- Inclusion of adult HGG patients with hydrocephalus who underwent CSF diversion.
- Analysis of primary outcomes: symptomatic improvement, survival, and KPS; secondary outcomes: hydrocephalus risk and CSF diversion complications.
Main Results:
- Hydrocephalus affects approximately 8% of HGG patients.
- Common symptoms include cognitive decline, gait disturbance, and headache.
- CSF diversion led to significant symptomatic improvement (79%) and a mean KPS increase of 15.04 points.
- Median survival post-diversion was 4.7 months; complication rate was 28% without reported peritoneal seeding.
Conclusions:
- CSF diversion offers significant benefits for symptom and functional improvement in HGG-associated hydrocephalus.
- The procedure may be a valuable option when prioritizing patient functionality and symptom relief.
- Further research may refine indications and management strategies for CSF diversion in HGG patients.
Background And Objectives:
The role of cerebrospinal fluid (CSF) diversion in patients with high-grade glioma (HGG)-associated hydrocephalus is debated. This systematic review and meta-analysis summarizes the risk factors, indications, and effectiveness of CSF diversion in patients with HGG-associated hydrocephalus, with the goal of evaluating patient survival, functional improvement, and symptomatic improvement after CSF diversion.
Methods:
PubMed, SCOPUS, CINAHL, Cochrane, and Embase databases were queried according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify studies describing adult HGG patients with hydrocephalus who underwent CSF diversion. Primary outcomes included symptomatic improvement, survival after CSF diversion, and Karnofsky Performance Status (KPS) before and after CSF diversion. Secondary outcomes included risk of hydrocephalus with ventricular opening during initial tumor resection, and CSF diversion-related complications and mortality.
Results:
A total of 15 studies yielded 4901 patients with HGG, of whom 333 suffered from HGG-associated hydrocephalus. Pooled proportion of patients with hydrocephalus among those with HGG was 8% (95% CI 3.63-16.3). Of 248 patients for which presenting symptoms of hydrocephalus were reported, the most common symptoms were cognitive decline (n = 110, 44%), gait disturbance (n = 87, 35%), headache (n = 79, 32%), and deteriorating consciousness (n = 48, 19%). After CSF diversion, 79% (95% CI 70.1-89.7, P < .01) of patients demonstrated symptomatic improvement. In studies that reported both pre- and post-shunt KPS score, there was a pooled mean increase of 15.04 points (95% CI 10.16-19.91, P < .00001) after shunting. The average, nonweighted median post-CSF diversion survival was 4.7 months (range, 2.7-7 months). The complication rate of CSF diversion was 28% (67/243) for patients in publications that reported complications. No cases of peritoneal seeding after CSF diversion were reported in the included studies.
Conclusion:
CSF diversion in adults with HGG-associated hydrocephalus led to a significant improvement in both KPS score and symptoms. If functionality and symptom improvement are patients' priorities, CSF diversion may be recommended.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology

